Applied Genetic Technologies (AGTC) Tops Q3 EPS by 6c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of $0.11, $0.06 better than the analyst estimate of $0.05. Revenue for the quarter came in at $12 million versus the consensus estimate of $12.98 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Community West Bancshares (CWBC) Tops Q1 EPS by 7c
• Hilltop Holdings (HTH) Tops Q1 EPS by 17c